Caprock Group LLC acquired a new stake in Genpact Limited (NYSE:G – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The fund acquired 54,501 shares of the business services provider’s stock, valued at approximately $2,471,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Krilogy Financial LLC bought a new stake in shares of Genpact in the third quarter valued at approximately $400,000. Johnson Investment Counsel Inc. raised its holdings in Genpact by 0.6% during the 3rd quarter. Johnson Investment Counsel Inc. now owns 54,138 shares of the business services provider’s stock valued at $2,268,000 after acquiring an additional 311 shares during the period. ProShare Advisors LLC lifted its position in shares of Genpact by 27.5% during the third quarter. ProShare Advisors LLC now owns 153,260 shares of the business services provider’s stock worth $6,420,000 after acquiring an additional 33,056 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Genpact by 28.0% in the third quarter. Smartleaf Asset Management LLC now owns 1,381 shares of the business services provider’s stock worth $58,000 after acquiring an additional 302 shares during the period. Finally, C WorldWide Group Holding A S boosted its holdings in shares of Genpact by 24.8% in the third quarter. C WorldWide Group Holding A S now owns 69,857 shares of the business services provider’s stock worth $2,926,000 after acquiring an additional 13,890 shares during the period. Institutional investors own 96.03% of the company’s stock.
Genpact Stock Performance
Genpact stock opened at $36.30 on Friday. Genpact Limited has a fifty-two week low of $34.79 and a fifty-two week high of $55.84. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.51 and a current ratio of 1.66. The stock has a market cap of $6.26 billion, a P/E ratio of 11.60, a price-to-earnings-growth ratio of 1.09 and a beta of 0.74. The firm’s fifty day moving average price is $45.36 and its 200-day moving average price is $43.54.
Genpact Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Monday, March 16th will be paid a dividend of $0.1875 per share. This represents a $0.75 annualized dividend and a dividend yield of 2.1%. This is a boost from Genpact’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Monday, March 16th. Genpact’s payout ratio is 21.73%.
Insider Buying and Selling
In other news, SVP Sameer Dewan sold 15,088 shares of the company’s stock in a transaction on Tuesday, January 13th. The shares were sold at an average price of $46.65, for a total value of $703,855.20. Following the completion of the sale, the senior vice president owned 37,749 shares of the company’s stock, valued at approximately $1,760,990.85. This represents a 28.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Riju Vashisht sold 16,016 shares of Genpact stock in a transaction on Tuesday, January 13th. The stock was sold at an average price of $46.65, for a total transaction of $747,146.40. Following the completion of the transaction, the senior vice president owned 95,521 shares in the company, valued at approximately $4,456,054.65. The trade was a 14.36% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 3.07% of the company’s stock.
Genpact News Summary
Here are the key news stories impacting Genpact this week:
- Positive Sentiment: Zacks highlights Genpact’s growth attributes and makes a bullish case that the company could deliver strong returns based on its business model and earnings momentum. Genpact (G) is an Incredible Growth Stock: 3 Reasons Why
- Positive Sentiment: Zacks also argues the recent heavy selling may be exhausted — the stock has moved into oversold technical territory and analysts have been raising estimates, which could set the stage for a turnaround. Down 21.6% in 4 Weeks, Here’s Why Genpact (G) Looks Ripe for a Turnaround
- Neutral Sentiment: Yahoo Finance summarizes five analyst questions from Genpact’s Q4 earnings call — useful for understanding management’s guidance and execution risks but not a direct buy/sell catalyst on its own. 5 Insightful Analyst Questions From Genpact’s Q4 Earnings Call
- Neutral Sentiment: Zacks' comparison piece on Genpact vs. Dynatrace examines relative valuation and sector fit — helpful for investors weighing alternatives but not a direct company catalyst. G vs. DT: Which Stock Is the Better Value Option?
- Neutral Sentiment: MSN coverage notes Genpact delivered record results but emphasizes that analyst sentiment remains cautious — reinforces the idea of solid fundamentals paired with conservative street expectations. Genpact (G) delivers record results as analyst sentiment stays cautious
- Negative Sentiment: Mizuho lowered its price target on Genpact to $49 — a direct near-term negative for sentiment and one of the principal reasons traders may be selling. Mizuho Lowers Genpact (NYSE:G) Price Target to $49.00
- Negative Sentiment: Brokerage coverage averages to a “Hold” rating, indicating the consensus view is cautious — less conviction from the sell-side can limit buying interest until clearer upside catalysts appear. Genpact Limited (NYSE:G) Receives Average Rating of “Hold” from Brokerages
Analyst Ratings Changes
A number of brokerages recently issued reports on G. Needham & Company LLC dropped their price objective on Genpact from $53.00 to $50.00 and set a “buy” rating on the stock in a report on Friday, February 6th. Susquehanna set a $42.00 target price on Genpact in a report on Friday, February 6th. Citigroup raised shares of Genpact to a “hold” rating in a report on Thursday, October 23rd. Mizuho reduced their price objective on shares of Genpact from $51.00 to $49.00 and set a “neutral” rating for the company in a research note on Tuesday. Finally, Wall Street Zen upgraded shares of Genpact from a “hold” rating to a “buy” rating in a research note on Saturday, January 10th. One investment analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Genpact presently has a consensus rating of “Hold” and an average target price of $47.29.
About Genpact
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
See Also
- Five stocks we like better than Genpact
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
